Closed consultation

Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Original consultation

This consultation ran from to

Summary

MHRA is seeking views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy to general sale list.

Documents

Consultation description

This consultation seeks your views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy (P) to general sale list (GSL).

Please comment on the proposal in the document above using the reply form that is included.

Comments should be sent to MHRA by 17 March 2014. Comments received after that date will not be considered.